Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
13F holders, Q3 2023
Institutional positions in Cero Therapeutics Holdings, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −3 vs. Q2 2023
- Shares held
- 830.1K
- −301.4K (−26.6%) vs. Q2 2023
- Total value
- $7.33M
- −$3.28M (−30.9%) vs. Q2 2023
- New holders
- 1
- 1 more added
- Sold out
- 4
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 11 | $798.7K |
| Q2 2025 | 8 | $2.38M |
| Q1 2025 | 15 | $527.7K |
| Q4 2024 | 21 | $800.3K |
| Q3 2024 | 18 | $320.0K |
| Q2 2024 | 15 | $557.1K |
| Q1 2024 | 9 | $4.85M |
| Q4 2023 | 10 | $7.49M |
| Q3 2023 | 10 | $7.33M |
| Q2 2023 | 13 | $10.6M |
| Q1 2023 | 17 | $12.5M |
| Q4 2022 | 46 | $101.1M |
| Q3 2022 | 66 | $153.0M |
| Q2 2022 | 54 | $144.5M |
| Q1 2022 | 45 | $137.2M |
| Q4 2021 | 36 | $104.2M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meteora Capital, LLC | 169,897 | $1.84M | 0.31% | +17,837+11.7% | Added |
| Mint Tower Capital Management B.V. | 141,089 | $1.53M | 0.43% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 108,103 | $1.18M | 0.32% | 00.0% | Unchanged |
| Clear Street LLC | 73,364 | $796.7K | 0.04% | −117,736−61.6% | Reduced |
| Shaolin Capital Management LLC | 50,000 | $543.0K | 0.02% | +50,000 | New |
| Walleye Capital LLC | 47,936 | $520.6K | 0.01% | 00.0% | Unchanged |
| Berkley W R Corp | 47,199 | $512.6K | 0.03% | −49,578−51.2% | Reduced |
| Walleye Trading LLC | 26,964 | $292.8K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,588 | $115.0K | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 155,000 | $2 | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −79,873−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −2,084−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −6−100.0% | Sold out |